SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Allscripts Healthcare Solutions, Inc. – ‘10-Q’ for 6/30/18 – ‘R7’

On:  Monday, 8/6/18, at 9:18am ET   ·   For:  6/30/18   ·   Accession #:  1564590-18-19295   ·   File #:  1-35547

Previous ‘10-Q’:  ‘10-Q’ on 5/8/18 for 3/31/18   ·   Next:  ‘10-Q’ on 11/2/18 for 9/30/18   ·   Latest:  ‘10-Q’ on 11/7/22 for 9/30/22   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/06/18  Allscripts Healthcare Soluti… Inc 10-Q        6/30/18  106:22M                                    ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.36M 
 2: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML    501K 
                Liquidation or Succession                                        
 3: EX-2.2      Plan of Acquisition, Reorganization, Arrangement,   HTML    524K 
                Liquidation or Succession                                        
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     38K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     38K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     33K 
13: R1          Document and Entity Information                     HTML     52K 
14: R2          Consolidated Balance Sheets (Unaudited)             HTML    161K 
15: R3          Consolidated Balance Sheets (Unaudited)             HTML     54K 
                (Parenthetical)                                                  
16: R4          Consolidated Statements of Operations (Unaudited)   HTML    131K 
17: R5          Consolidated Statements of Comprehensive Income     HTML     63K 
                (Loss) (Unaudited)                                               
18: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML    127K 
19: R7          Basis of Presentation and Significant Accounting    HTML     49K 
                Policies                                                         
20: R8          Revenue from Contracts with Customers               HTML    611K 
21: R9          Business Combinations                               HTML    172K 
22: R10         Fair Value Measurements and Long-term Investments   HTML    183K 
23: R11         Stockholders' Equity                                HTML    142K 
24: R12         Earnings (Loss) Per Share                           HTML    249K 
25: R13         Goodwill and Intangible Assets                      HTML    262K 
26: R14         Debt                                                HTML    309K 
27: R15         Income Taxes                                        HTML     68K 
28: R16         Derivative Financial Instruments                    HTML    212K 
29: R17         Other Comprehensive Income                          HTML    365K 
30: R18         Contingencies                                       HTML     40K 
31: R19         Discontinued Operations                             HTML    137K 
32: R20         Business Segments                                   HTML    196K 
33: R21         Supplemental Disclosures                            HTML     80K 
34: R22         Subsequent Events                                   HTML     38K 
35: R23         Basis of Presentation and Significant Accounting    HTML     83K 
                Policies (Policies)                                              
36: R24         Revenue from Contracts with Customers (Tables)      HTML    575K 
37: R25         Business Combinations (Tables)                      HTML    161K 
38: R26         Fair Value Measurements and Long-term Investments   HTML    179K 
                (Tables)                                                         
39: R27         Stockholders' Equity (Tables)                       HTML    135K 
40: R28         Earnings (Loss) Per Share (Tables)                  HTML    251K 
41: R29         Goodwill and Intangible Assets (Tables)             HTML    257K 
42: R30         Debt (Tables)                                       HTML    309K 
43: R31         Income Taxes (Tables)                               HTML     60K 
44: R32         Derivative Financial Instruments (Tables)           HTML    211K 
45: R33         Other Comprehensive Income (Tables)                 HTML    366K 
46: R34         Discontinued Operations (Tables)                    HTML    140K 
47: R35         Business Segments (Tables)                          HTML    188K 
48: R36         Supplemental Disclosures (Tables)                   HTML     79K 
49: R37         Basis of Presentation and Significant Accounting    HTML     38K 
                Policies - Additional Information (Detail)                       
50: R38         Revenue from Contracts with Customers - Additional  HTML     84K 
                Information (Detail)                                             
51: R39         Revenue from Contracts with Customers - Impact of   HTML     66K 
                Adoption on Previously Reported Condensed                        
                Consolidated Balance Sheet (Detail)                              
52: R40         Revenue from Contracts with Customers - Schedule    HTML     67K 
                of Comparison Between Reported Statements to                     
                Pro-forma Amounts in Effect of Previous Guidance -               
                Consolidated Balance Sheet (Detail)                              
53: R41         Revenue from Contracts with Customers - Schedule    HTML     78K 
                of Comparison Between Reported Statements to                     
                Pro-forma Amounts in Effect of Previous Guidance -               
                Statement of Operations (Detail)                                 
54: R42         Revenue from Contract with Customer - Summary of    HTML     43K 
                Revenue Regognized Related to Various Performance                
                Obligations and Elected accounting Expedients                    
                (Detail)                                                         
55: R43         Revenue from Contracts with Customers - Summary of  HTML     71K 
                Revenue by Type and Nature of Revenue Stream by                  
                Reportable Segments (Detail)                                     
56: R44         Business Combinations - Agreement to Acquire        HTML     60K 
                Health Grid - Additional Information (Detail)                    
57: R45         Schedule of Consideration Transaction (Detail)      HTML     54K 
58: R46         Assets Acquired and Liabilities Assumed (Detail)    HTML     72K 
59: R47         Acquired Intangible Assets Amortization (Detail)    HTML     56K 
60: R48         Business Combinations - Acquisition of Practice     HTML     50K 
                Fusion, Inc - Additional Information (Detail)                    
61: R49         Business Combinations - Other Acquisitions and      HTML    120K 
                Divestiture - Additional Information (Detail)                    
62: R50         Business Combinations - Acquisition of DeVero -     HTML     40K 
                Additional Information (Detail)                                  
63: R51         Business Combinations - Acquisition of the          HTML     39K 
                Patient/Provider Engagement Solutions Business                   
                from NantHealth, Inc. - Additional Information                   
                (Detail)                                                         
64: R52         Business Combinations and Other Investments -       HTML     54K 
                Acquisition of the Enterprise Information                        
                Solutions Business from McKesson Corporation -                   
                Additional Information (Detail)                                  
65: R53         Business Combinations - Formation of Joint          HTML     42K 
                Business Entity and Acquisition of Netsmart, Inc -               
                Additional Information (Detail)                                  
66: R54         Pro forma Results (Detail)                          HTML     38K 
67: R55         Fair Value Measurements and Long-term Investments   HTML     45K 
                - Additional Information (Detail)                                
68: R56         Summary of Financial Assets and Liabilities         HTML     72K 
                Measured at Fair Value on Recurring Basis (Detail)               
69: R57         Summary of Changes in Assets and Liabilities        HTML     40K 
                Measured at Fair Value on Recurring Basis (Detail)               
70: R58         Summary of Long-term Equity Investments Included    HTML     51K 
                in Other Assets (Detail)                                         
71: R59         Stockholders' Equity - Additional Information       HTML     64K 
                (Detail)                                                         
72: R60         Stock-Based Compensation Expense (Benefit)          HTML     47K 
                (Detail)                                                         
73: R61         Stock-Based Awards Granted (Detail)                 HTML     44K 
74: R62         Calculations of Earnings (Loss) Per Share (Detail)  HTML     95K 
75: R63         Anti-Dilutive Stock Options, Restricted Stock Unit  HTML     34K 
                Awards and Warrants Excluded from Computation of                 
                Diluted Earnings (Loss) Per Share (Detail)                       
76: R64         Goodwill and Intangible Assets (Detail)             HTML     50K 
77: R65         Changes in Carrying Amount of Goodwill (Detail)     HTML     84K 
78: R66         Goodwill and Intangible Assets - Additional         HTML     64K 
                Information (Detail)                                             
79: R67         Debt Outstanding Excluding Capital Leases (Detail)  HTML     66K 
80: R68         Interest Expense (Detail)                           HTML     46K 
81: R69         Interest Expense Related to 1.25% Notes (Detail)    HTML     39K 
82: R70         Debt - Additional Information (Detail)              HTML    138K 
83: R71         Summary of Future Debt Payment Obligations          HTML     78K 
                (Detail)                                                         
84: R72         Summary of Future Debt Payment Obligations          HTML     34K 
                (Parenthetical) (Detail)                                         
85: R73         Effective Tax Rates (Detail)                        HTML     40K 
86: R74         Income Taxes - Additional Information (Detail)      HTML     65K 
87: R75         Fair Value and Balance Sheet Locations - (Detail)   HTML     53K 
88: R76         Derivative Financial Instruments - Additional       HTML     67K 
                Information (Detail)                                             
89: R77         Derivatives Instruments Designated as Cash Flow     HTML     46K 
                Hedges - (Detail)                                                
90: R78         Net Impact of Changes in Fair Value of Call Option  HTML     39K 
                and Embedded Cash Conversion Option - (Detail)                   
91: R79         Components of Accumulated Other Comprehensive Loss  HTML     61K 
                (Detail)                                                         
92: R80         Components of Accumulated Other Comprehensive Loss  HTML     38K 
                (Parenthetical) (Detail)                                         
93: R81         Income Tax Effects Related to Components of Other   HTML    115K 
                Comprehensive Income (Loss) (Detail)                             
94: R82         Income Tax Effects Related to Components of Other   HTML     34K 
                Comprehensive Income (Loss) (Parenthetical)                      
                (Detail)                                                         
95: R83         Contingencies - Additional Information (Detail)     HTML     32K 
96: R84         Discontinued Operations - Additional Information    HTML     40K 
                (Detail)                                                         
97: R85         Summary of Major Classes of Assets and Liabilities  HTML     66K 
                of Discontinued Operations (Detail)                              
98: R86         Summary of Major Classes of Line Items              HTML     69K 
                Constituting Income (Loss) of Discontinued                       
                Operations (Detail)                                              
99: R87         Business Segments - Additional Information          HTML     44K 
                (Detail)                                                         
100: R88         Revenues and Income from Operations Related to      HTML     55K  
                Segment Within Reconciliation to Consolidated                    
                Amounts (Detail)                                                 
101: R89         Supplemental Disclosures - Additional Information   HTML     40K  
                (Detail)                                                         
102: R90         Supplemental Disclosures (Detail)                   HTML     55K  
103: R91         Subsequent Events - Additional Information          HTML     51K  
                (Detail)                                                         
105: XML         IDEA XML File -- Filing Summary                      XML    202K  
104: EXCEL       IDEA Workbook of Financial Reports                  XLSX    129K  
 7: EX-101.INS  XBRL Instance -- mdrx-20180630                       XML   7.02M 
 9: EX-101.CAL  XBRL Calculations -- mdrx-20180630_cal               XML    316K 
10: EX-101.DEF  XBRL Definitions -- mdrx-20180630_def                XML   1.01M 
11: EX-101.LAB  XBRL Labels -- mdrx-20180630_lab                     XML   1.55M 
12: EX-101.PRE  XBRL Presentations -- mdrx-20180630_pre              XML   1.48M 
 8: EX-101.SCH  XBRL Schema -- mdrx-20180630                         XSD    243K 
106: ZIP         XBRL Zipped Folder -- 0001564590-18-019295-xbrl      Zip    310K  


‘R7’   —   Basis of Presentation and Significant Accounting Policies


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.10.0.1
Basis of Presentation and Significant Accounting Policies
6 Months Ended
Accounting Policies [Abstract]  
Basis of Presentation and Significant Accounting Policies

1. Basis of Presentation and Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the accounts of Allscripts Healthcare Solutions, Inc. (“Allscripts”) and its wholly-owned subsidiaries and controlled affiliates. All significant intercompany balances and transactions have been eliminated. Each of the terms “we,” “us,” “our” or the “Company” as used herein refers collectively to Allscripts Healthcare Solutions, Inc. and its wholly-owned subsidiaries and controlled affiliates, unless otherwise stated.

Unaudited Interim Financial Information

The unaudited interim consolidated financial statements as of and for the three and six months ended June 30, 2018 and 2017 have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. These interim consolidated financial statements are unaudited and, in the opinion of our management, include all adjustments, consisting of normal recurring adjustments and accruals, necessary to present fairly the consolidated financial statements for the periods presented in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The consolidated results of operations for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be expected for the full year ending December 31, 2018.

Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted in accordance with the SEC's rules and regulations for interim reporting, although the Company believes that the disclosures made are adequate to make that information not misleading. These unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2017 (our “Form 10-K”).

Use of Estimates

The preparation of consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and the accompanying notes. Actual results could differ materially from these estimates.

Change in Presentation

During the first quarter of 2018, we changed the presentation of certain bundled revenue streams.  Such revenue was previously included as part of software delivery, support and maintenance revenue.  Under the new presentation, such revenue is included as part of client services revenue.  The revenues previously reported for the three and six months ended June 30, 2017 have been recast to match the new presentation by reducing software delivery, support and maintenance and increasing client services by $4.2 million and $8.5 million, respectively.

Significant Accounting Policies

We adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers: Topic 606 (“ASC 606”) effective on January 1, 2018 using the modified retrospective method for all contracts not completed as of the date of adoption. There have been no other significant changes to our significant accounting policies from those disclosed in our Form 10-K.

Recently Adopted Accounting Pronouncements

In January 2016, the FASB issued Accounting Standards Update No. 2016-01, “Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). The amendments in ASU 2016-01 modify the requirements related to the measurement of certain financial instruments in the statement of financial condition and results of operation. Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) are required to be measured at fair value with changes in fair value recognized in net income. An entity may continue to elect to measure equity investments which do not have a readily determinable fair value at cost with adjustments for impairment, if any, and observable changes in price. In addition, for a liability (other than a derivative liability) that an entity measures at fair value, any change in fair value related to the instrument-specific credit risk (i.e., the entity’s own credit risk), should be presented separately in other comprehensive income and not as a component of net income. ASU 2016-01 also clarifies that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for sale securities in combination with the entity’s other deferred tax assets. ASU 2016-01 is effective for interim and annual periods beginning after December 15, 2017 with early adoption permitted   solely for the instrument-instrument specific credit risk for liabilities measured at fair value. The amendments should be applied by means of a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) should be applied prospectively to equity investments that exist as of the date of adoption. We adopted ASU 2016-01 effective January 1, 2018 and there was no immediate impact upon adoption. Refer to Note 4, “Fair Value Measurements and Long-term Investments,” for additional information regarding our unconsolidated equity investments.

In January 2017, the FASB issued Accounting Standards Update No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business (“ASU 2017-01”). ASU 2017-01 provides new accounting guidance to assist an entity in evaluating when a set of transferred assets and activities is a business.  The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, and should be applied prospectively to any transactions occurring within the period of adoption. We adopted ASU 2017-01 effective January 1, 2018 and there was no immediate impact upon adoption.

Accounting Pronouncements Not Yet Adopted

In June 2018, the FASB issued Accounting Standards Update No. 2018-07, “Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting” (“ASU 2018-07”), which expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in its own operations by issuing share-based payment awards. ASU 2018-07 also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under ASC 606. ASU 2018-07 is effective for interim and annual periods beginning after December 15, 2018. We are currently evaluating the impact of this accounting guidance, including the timing of adoption.

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”), intended to improve financial reporting about leasing transactions. The new guidance will require entities that lease assets to recognize on their balance sheets the assets and liabilities for the rights and obligations created by those leases and to disclose key information about the leasing arrangements. ASU 2016-02 is effective for interim and annual periods beginning after December 15, 2018 with early adoption permitted. We are currently gathering lease data and have selected specific software to assist us in recording and maintaining an inventory of leases. We will adopt ASU 2016-02 on January 1, 2019 and we are currently evaluating its financial statement impact.

In January 2017, the FASB issued Accounting Standards Update No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU 2017-04”), which provides new accounting guidance to simplify the accounting for goodwill impairment. ASU 2017-04 removes Step Two of the goodwill impairment test, which requires a hypothetical purchase price allocation. Under the new guidance, a goodwill impairment will equal the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill assigned to the reporting unit. All other goodwill impairment guidance will remain largely unchanged. Entities will continue to have the option to perform a qualitative assessment to determine if a quantitative impairment test is necessary. ASU 2017-04 is effective for annual and interim periods in fiscal years beginning after December 15, 2019 with early adoption permitted for any goodwill impairment tests performed after January 1, 2017. The new guidance is to be applied prospectively. We are currently evaluating the impact of this accounting guidance, including the timing of adoption.

In August 2017, the FASB issued Accounting Standards Update No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities (“ASU 2017-12”), which provides new accounting guidance to simplify and improve the reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. In addition to that main objective, the amendments in this Update make certain targeted improvements to simplify the application of the hedge accounting guidance in current GAAP. ASU 2017-12 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early application is permitted in any interim period after the issuance of this Update. We are currently evaluating the impact of this accounting guidance, including the timing of adoption.

We do not believe that any other recently issued, but not yet effective accounting standards, if adopted, would have a material impact on our consolidated financial statements.


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
12/15/19
1/1/19
12/31/1810-K,  8-K
12/15/18
Filed on:8/6/18
For Period end:6/30/18
1/1/18
12/31/1710-K
12/15/174,  8-K/A
6/30/1710-Q
1/1/17
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/29/22  Veradigm Inc.                     10-K/A     12/31/21   12:4M                                     Donnelley … Solutions/FA
 2/25/22  Veradigm Inc.                     10-K       12/31/21  150:28M                                    Donnelley … Solutions/FA
 2/26/21  Veradigm Inc.                     10-K       12/31/20  165:35M                                    ActiveDisclosure/FA
Top
Filing Submission 0001564590-18-019295   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 9:56:31.1am ET